Pathogenesis of myocarditis and dilated cardiomyopathy.

[1]  D. Pennell,et al.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. , 2008, European heart journal.

[2]  E. Wawrousek,et al.  Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities1 , 2008, The Journal of Immunology.

[3]  M. Kimura,et al.  Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. , 2008, The American journal of pathology.

[4]  Y. Allanore,et al.  Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs , 2008, Expert opinion on pharmacotherapy.

[5]  A. Alonso-Ruiz,et al.  Bmc Musculoskeletal Disorders Tumor Necrosis Factor Alpha Drugs in Rheumatoid Arthritis: Systematic Review and Metaanalysis of Efficacy and Safety , 2008 .

[6]  Y. Iwakura,et al.  Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category , 2008, The Journal of experimental medicine.

[7]  U. Eriksson,et al.  CD11b+ Monocytes Abrogate Th17 CD4+ T Cell-Mediated Experimental Autoimmune Myocarditis1 , 2008, The Journal of Immunology.

[8]  Noel R Rose,et al.  Genetic complexity of autoimmune myocarditis. , 2008, Autoimmunity reviews.

[9]  T. Mcclanahan,et al.  Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. , 2007, Gastroenterology.

[10]  L. Cooper,et al.  Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. , 2007, Journal of molecular and cellular cardiology.

[11]  K. Mansfield,et al.  Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease. , 2007, AIDS research and human retroviruses.

[12]  S. Vidal,et al.  Complex genetic control of host susceptibility to coxsackievirus B3-induced myocarditis , 2007, Genes and Immunity.

[13]  J. Granados,et al.  MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy. , 2007, Experimental and molecular pathology.

[14]  K. Peuhkurinen,et al.  Genetics of dilated cardiomyopathy , 2007, Annals of medicine.

[15]  N. Rose,et al.  Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. , 2007, Methods.

[16]  B. Ferry,et al.  Unusual case presentations associated with the CD45 C77G polymorphism , 2006, Clinical and experimental immunology.

[17]  M. Kurrer,et al.  Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis , 2006, European journal of immunology.

[18]  M. Andrassy,et al.  Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium , 2006, Circulation.

[19]  Y. Shoenfeld,et al.  Anti-phospholipid Syndrome , 2022 .

[20]  Kunimasa Suzuki,et al.  CD4 T Cells Play Major Effector Role and CD8 T Cells Initiating Role in Spontaneous Autoimmune Myocarditis of HLA-DQ8 Transgenic IAb Knockout Nonobese Diabetic Mice1 , 2006, The Journal of Immunology.

[21]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[22]  L. Presta,et al.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. , 2006, The Journal of clinical investigation.

[23]  Jared W. Magnani,et al.  Myocarditis: Current Trends in Diagnosis and Treatment , 2006, Circulation.

[24]  Wei Liu,et al.  Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality , 2006, Autoimmunity.

[25]  J. Carlin,et al.  Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.

[26]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[27]  S. Akira,et al.  Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3–Induced Myocarditis and Influences Type I Interferon Production , 2005, Circulation.

[28]  R. Kandolf,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.

[29]  K. Broman,et al.  Two Autoimmune Diabetes Loci Influencing T Cell Apoptosis Control Susceptibility to Experimental Autoimmune Myocarditis1 , 2005, The Journal of Immunology.

[30]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[31]  D. Kass,et al.  Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Rose,et al.  IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart1 , 2005, The Journal of Immunology.

[33]  N. Rose,et al.  Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus‐induced myocarditis , 2005, Reviews in medical virology.

[34]  D. Swerdlow,et al.  Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. , 2004, Journal of the American College of Cardiology.

[35]  Martin J. Lohse,et al.  Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy , 2004 .

[36]  D. Kass,et al.  Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. , 2004, The American journal of pathology.

[37]  Rajni B. Sharma,et al.  Animal models for autoimmune myocarditis and autoimmune thyroiditis. , 2004, Methods in molecular medicine.

[38]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[39]  W. McKenna,et al.  Eradication of viral myocarditis: is there hope? , 2003, Journal of the American College of Cardiology.

[40]  N. Rose,et al.  Thyroid-Specific Expression of IFN-γ Limits Experimental Autoimmune Thyroiditis by Suppressing Lymphocyte Activation in Cervical Lymph Nodes1 , 2003, The Journal of Immunology.

[41]  N. Rose,et al.  IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication1 , 2003, The Journal of Immunology.

[42]  G. Thiene,et al.  Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders , 2003, Circulation.

[43]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[44]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[45]  N. Rose,et al.  Cellular Immunity: A Role for Cytokines , 2003 .

[46]  N. Rose,et al.  Interleukin-12 Receptor/STAT4 Signaling Is Required for the Development of Autoimmune Myocarditis in Mice by an Interferon-&ggr;–Independent Pathway , 2001 .

[47]  M. Kurrer,et al.  Dual Role of the IL-12/IFN-γ Axis in the Development of Autoimmune Myocarditis: Induction by IL-12 and Protection by IFN-γ1 , 2001, The Journal of Immunology.

[48]  M. Leach,et al.  Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death , 2001, The Journal of Immunology.

[49]  N. Rose,et al.  From infection to autoimmunity. , 2001, Journal of autoimmunity.

[50]  S. Felix,et al.  Improvement of Cardiac Function after Immunoadsorption in Patients with Dilated Cardiomyopathy , 2001, Autoimmunity.

[51]  S. Solomon,et al.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.

[52]  M. Kamisago.  Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy , 2000 .

[53]  S. Wittmer,et al.  Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.

[54]  M. Yacoub,et al.  Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. , 2000, Transplantation.

[55]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[56]  A. Komiyama,et al.  Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing–remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide , 2000, Journal of Neuroimmunology.

[57]  B. Strauer,et al.  Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. , 2000, Journal of the American College of Cardiology.

[58]  M. Yacoub,et al.  Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients. , 1999, Biochemical and biophysical research communications.

[59]  J. Towbin,et al.  Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. , 1999, Circulation.

[60]  B. Diamond,et al.  Genetic control of autoimmune myocarditis mediated by myosin-specific antibodies , 1999, Immunogenetics.

[61]  P. Sakkinen,et al.  Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. , 1998, Advances in virus research.

[62]  G. Berry,et al.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. , 1997, The New England journal of medicine.

[63]  C. Chan,et al.  IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. , 1997, Journal of immunology.

[64]  B. McManus,et al.  Human leukocyte antigen class ii associations in patients with idiopathic dilated cardiomyopathy , 1997 .

[65]  S. Huang,et al.  High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. , 1997, Journal of immunology.

[66]  A. Jaffe,et al.  Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. , 1997, Circulation.

[67]  W. Cowden,et al.  IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. , 1996, Journal of immunology.

[68]  J. Penninger,et al.  Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. , 1996, The Journal of clinical investigation.

[69]  Rosalind S. Brown,et al.  Autoimmune thyroid disease in pregnant women and their offspring. , 1996, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[70]  K. Lafferty,et al.  The Th1/Th2 balance in autoimmunity. , 1995, Current opinion in immunology.

[71]  K. Beisel,et al.  Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart , 1995, The Journal of experimental medicine.

[72]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[73]  J. Carlquist,et al.  Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. , 1994, The American journal of cardiology.

[74]  D Glogar,et al.  Indium 111-monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme myopericarditis. , 1993, Archives of internal medicine.

[75]  A. Herskowitz,et al.  Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. , 1993, Journal of immunology.

[76]  J. Deckers,et al.  Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. , 1993, The American journal of cardiology.

[77]  A. Trikas,et al.  Clinical significance of antibodies against tropomyosin, actin and myosin in patients with dilated cardiomyopathy. , 1993, Journal of clinical & laboratory immunology.

[78]  W. Mckenna,et al.  Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. , 1992, Circulation.

[79]  J. Carlquist,et al.  HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. , 1991, Circulation.

[80]  K. Baughman,et al.  Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. , 1990, Journal of the American College of Cardiology.

[81]  I. Goldenberg,et al.  Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy. , 1990, American heart journal.

[82]  C. Limas,et al.  HLA antigens in idiopathic dilated cardiomyopathy. , 1989, British heart journal.

[83]  J E Parrillo,et al.  A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.

[84]  K. Beisel,et al.  Cardiac myosin induces myocarditis in genetically predisposed mice. , 1987, Journal of immunology.

[85]  I. Cohen,et al.  Infection and Autoimmunity , 1987 .

[86]  K. Beisel,et al.  Postinfectious Autoimmunity: Two Distinct Phases of Coxsackievirus B3‐Induced Myocarditis a , 1986, Annals of the New York Academy of Sciences.

[87]  K. Beisel,et al.  Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. , 1986, Journal of immunology.

[88]  T. Hamilton,et al.  The cell biology of macrophage activation. , 1984, Annual review of immunology.

[89]  K. Taylor,et al.  The autoimmune diseases. , 1965, The Medical clinics of North America.